Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 118,420 | 99,107 | 35,227 | 256,739 | 347,121 |
| Receivables | 776,215 | 614,687 | 742,291 | 663,762 | 640,302 |
| Inventories | 612,454 | 581,384 | 530,735 | 489,389 | 490,649 |
| TOTAL | $1,587,806 | $1,377,863 | $1,411,818 | $1,520,108 | $1,551,539 |
| Non-Current Assets | |||||
| PPE Net | 424,908 | 447,574 | 469,815 | 514,158 | 477,754 |
| Intangibles | 1,329,813 | 1,489,052 | 1,694,946 | 1,759,939 | 1,827,440 |
| Other Non-Current Assets | 158,918 | 158,080 | 222,762 | 145,459 | 149,300 |
| TOTAL | $1,913,639 | $2,094,706 | $2,387,523 | $2,419,556 | $2,454,494 |
| Total Assets | $3,501,445 | $3,472,569 | $3,799,341 | $3,939,664 | $4,006,033 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 324,213 | 213,125 | 89,961 | 30,614 | 44,228 |
| Accounts payable and accrued liabilities | 757,761 | 541,983 | 540,678 | 573,206 | 619,428 |
| Other current liabilities | 31,755 | 76,988 | 107,483 | 58,000 | N/A |
| TOTAL | $1,129,771 | $846,595 | $752,800 | $677,243 | $676,902 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,161,790 | 2,427,451 | 2,631,687 | 2,718,091 | 2,771,704 |
| Other Non-Current Liabilities | 276,386 | 143,241 | 355,678 | 167,811 | 174,783 |
| TOTAL | $2,481,186 | $2,605,963 | $2,862,562 | $2,895,448 | $2,984,199 |
| Total Liabilities | $3,610,957 | $3,452,558 | $3,615,362 | $3,572,691 | $3,661,101 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 309,966 | 307,007 | 303,618 | 301,541 | 299,821 |
| Common Shares | 3,099 | 3,066 | 3,036 | 3,014 | 2,997 |
| Retained earnings | -607,062 | -490,176 | -406,183 | -276,197 | -286,821 |
| Other shareholders' equity | -65,755 | -32,119 | -104,503 | -18,194 | 343 |
| TOTAL | $-109,512 | $20,011 | $183,979 | $366,973 | $344,932 |
| Total Liabilities And Equity | $3,501,445 | $3,472,569 | $3,799,341 | $3,939,664 | $4,006,033 |